期刊文献+

MUC1核心肽多克隆抗体的制备及鉴定 被引量:1

Preparation and Identification of Polyclonal Antibody Against MUC1 Core Peptide
下载PDF
导出
摘要 目的 制备MUC1核心肽多克隆抗体 ,用于靶向MUC1肿瘤治疗的研究。方法 以 8R -MUC1核心肽 6重复序列重组蛋白 (8R MUCPT)为抗原免疫家兔 ,以ELISA法确定抗MUC1多克隆抗体效价 ,以Westernblot和ELISA阻断试验鉴定抗体特异性。结果 MUC1核心肽多克隆抗体效价为 1∶2 5 6 0 0 0 ,能与MUC1核心肽特异性结合。结论 利用原核表达的 8R -MUCPT蛋白 ,可有效地诱导免疫动物产生MUC1核心肽特异性抗体 ,为MUC1核心肽靶向肿瘤特异性免疫研究提供了有力的实验材料。 Objective To prepare anti-MUC1 core peptide polyclonal antibody used as target in immunotherapy of tumors.Methods Immunize rabbits with recombinant 8R-MUC1 core peptide protein with s ix tandem repeat sequence,and determine the titer of polyclonal antibody against MUC1 by ELISA.The specificity of antibody were identified by Western blot and b locking ELISA separately.Results The polyclonal antibody agains t MUC1,with a titer of 1∶256 000,bound specifically to MUC1 core peptide. Conclusion The 8R-MUCPT protein expressed in prokaryotic system effe ctively induced specific antibody against MUC1 core peptide in immunized animals .It provided an important experimental materials for the study on tumor-targeti ng MUC1 core peptide in immunotherapy. [
出处 《中国生物制品学杂志》 CAS CSCD 2005年第2期135-137,共3页 Chinese Journal of Biologicals
  • 相关文献

参考文献6

  • 1Ho SB,Nichols GA, Lyftogt C,et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res, 1993,53:641-651.
  • 2Finn OJ,Jerome KR, Henderson RA, et al. MUC1 epithelial tumor mucin based immunity and cancer vaccines. Immunol Rev,1995,145:61-89.
  • 3He J,Shen D,O'Donnell MA,et al. Induction of MUCl-specific cellular immunity by a recombinant BCG expressing human MUC1 and secreting IL-2. Int J Oncol,2002,20(6): 1305-1311.
  • 4Croce MV, Isla-Larrain MT, Demichelis SO, et al. Tissue and serum MUC1 mucin detection in breast cancer patients. Breast Cancer Res Treat,2003,81:195-207.
  • 5Grosso JF, Herbert LM,Owen JL,et al. MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2. J Immuol,2004,173(3): 1721-1730.
  • 6Imai M,Ohta R,Okada N,et al. Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma. Int J Cancer, 2004, 110(6): 875-881.

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部